vs

Side-by-side financial comparison of CHICAGO RIVET & MACHINE CO (CVR) and IMMUCELL CORP (ICCC). Click either name above to swap in a different company.

CHICAGO RIVET & MACHINE CO is the larger business by last-quarter revenue ($6.0M vs $5.5M, roughly 1.1× IMMUCELL CORP). IMMUCELL CORP runs the higher net margin — -2.5% vs -19.3%, a 16.8% gap on every dollar of revenue. On growth, CHICAGO RIVET & MACHINE CO posted the faster year-over-year revenue change (45.9% vs -8.4%). CHICAGO RIVET & MACHINE CO produced more free cash flow last quarter ($24.3K vs $-1.8M). Over the past eight quarters, IMMUCELL CORP's revenue compounded faster (3.9% CAGR vs -12.7%).

Chicago Pneumatic, also known as "CP", is an industrial manufacturer providing power tools, air compressors, generators, light towers and hydraulic equipment. Products are sold in more than 150 countries through a worldwide distribution network. CP is active on markets such as tools for industrial production, vehicle service, maintenance repair operation for mining, construction, infrastructure equipment.

ImmuCell Corp is a US-based animal health biotechnology company that develops, manufactures and markets innovative products for livestock, primarily dairy cattle. Its core offerings include preventive and therapeutic solutions for common bovine health issues such as mastitis, serving agricultural producers and veterinary providers across North America.

CVR vs ICCC — Head-to-Head

Bigger by revenue
CVR
CVR
1.1× larger
CVR
$6.0M
$5.5M
ICCC
Growing faster (revenue YoY)
CVR
CVR
+54.3% gap
CVR
45.9%
-8.4%
ICCC
Higher net margin
ICCC
ICCC
16.8% more per $
ICCC
-2.5%
-19.3%
CVR
More free cash flow
CVR
CVR
$1.8M more FCF
CVR
$24.3K
$-1.8M
ICCC
Faster 2-yr revenue CAGR
ICCC
ICCC
Annualised
ICCC
3.9%
-12.7%
CVR

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CVR
CVR
ICCC
ICCC
Revenue
$6.0M
$5.5M
Net Profit
$-1.2M
$-139.7K
Gross Margin
2.7%
42.9%
Operating Margin
-15.3%
0.4%
Net Margin
-19.3%
-2.5%
Revenue YoY
45.9%
-8.4%
Net Profit YoY
68.0%
80.1%
EPS (diluted)
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVR
CVR
ICCC
ICCC
Q4 25
$6.0M
Q3 25
$7.4M
$5.5M
Q2 25
$7.3M
$6.4M
Q1 25
$7.2M
$8.1M
Q4 24
$4.1M
$7.8M
Q3 24
$7.0M
$6.0M
Q2 24
$8.1M
$5.5M
Q1 24
$7.9M
$7.3M
Net Profit
CVR
CVR
ICCC
ICCC
Q4 25
$-1.2M
Q3 25
$67.6K
$-139.7K
Q2 25
$-395.0K
$501.9K
Q1 25
$401.0K
$1.4M
Q4 24
$-3.6M
Q3 24
$-1.4M
$-701.7K
Q2 24
$142.1K
$-1.5M
Q1 24
$-698.0K
$-437.9K
Gross Margin
CVR
CVR
ICCC
ICCC
Q4 25
2.7%
Q3 25
18.1%
42.9%
Q2 25
13.4%
43.7%
Q1 25
22.9%
41.6%
Q4 24
-43.7%
36.5%
Q3 24
10.0%
26.3%
Q2 24
17.6%
22.5%
Q1 24
9.5%
31.6%
Operating Margin
CVR
CVR
ICCC
ICCC
Q4 25
-15.3%
Q3 25
0.9%
0.4%
Q2 25
-5.7%
8.8%
Q1 25
1.0%
13.9%
Q4 24
-86.4%
8.0%
Q3 24
-11.8%
-9.6%
Q2 24
1.3%
-25.3%
Q1 24
-11.5%
-4.1%
Net Margin
CVR
CVR
ICCC
ICCC
Q4 25
-19.3%
Q3 25
0.9%
-2.5%
Q2 25
-5.4%
7.8%
Q1 25
5.5%
17.9%
Q4 24
-88.0%
Q3 24
-20.8%
-11.7%
Q2 24
1.8%
-28.0%
Q1 24
-8.9%
-6.0%
EPS (diluted)
CVR
CVR
ICCC
ICCC
Q4 25
Q3 25
$-0.02
Q2 25
$0.06
Q1 25
$0.16
Q4 24
$0.09
Q3 24
$-0.09
Q2 24
$-0.20
Q1 24
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVR
CVR
ICCC
ICCC
Cash + ST InvestmentsLiquidity on hand
$1.7M
$3.9M
Total DebtLower is stronger
$9.5M
Stockholders' EquityBook value
$18.8M
$29.8M
Total Assets
$23.3M
$45.7M
Debt / EquityLower = less leverage
0.32×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVR
CVR
ICCC
ICCC
Q4 25
$1.7M
Q3 25
$1.7M
$3.9M
Q2 25
$1.2M
Q1 25
$765.6K
Q4 24
$2.2M
$3.8M
Q3 24
$2.2M
Q2 24
$2.6M
$1.3M
Q1 24
$2.7M
$960.3K
Total Debt
CVR
CVR
ICCC
ICCC
Q4 25
Q3 25
$9.5M
Q2 25
Q1 25
$8.7M
Q4 24
$0
$9.0M
Q3 24
$9.4M
Q2 24
$9.8M
Q1 24
$10.2M
Stockholders' Equity
CVR
CVR
ICCC
ICCC
Q4 25
$18.8M
Q3 25
$20.0M
$29.8M
Q2 25
$20.0M
$29.9M
Q1 25
$20.4M
$29.0M
Q4 24
$20.0M
$27.5M
Q3 24
$23.7M
$26.4M
Q2 24
$25.2M
$23.5M
Q1 24
$25.2M
$24.6M
Total Assets
CVR
CVR
ICCC
ICCC
Q4 25
$23.3M
Q3 25
$24.0M
$45.7M
Q2 25
$23.6M
$46.7M
Q1 25
$24.1M
$45.6M
Q4 24
$23.4M
$45.1M
Q3 24
$26.4M
$44.4M
Q2 24
$27.3M
$41.9M
Q1 24
$27.8M
$43.1M
Debt / Equity
CVR
CVR
ICCC
ICCC
Q4 25
Q3 25
0.32×
Q2 25
Q1 25
0.30×
Q4 24
0.00×
0.33×
Q3 24
0.36×
Q2 24
0.42×
Q1 24
0.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVR
CVR
ICCC
ICCC
Operating Cash FlowLast quarter
$116.4K
$-1.2M
Free Cash FlowOCF − Capex
$24.3K
$-1.8M
FCF MarginFCF / Revenue
0.4%
-32.3%
Capex IntensityCapex / Revenue
1.5%
10.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-1.6M
$715.4K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVR
CVR
ICCC
ICCC
Q4 25
$116.4K
Q3 25
$638.0K
$-1.2M
Q2 25
$28.2K
$1.6M
Q1 25
$-2.0M
$1.6M
Q4 24
$-60.1K
$-3.1K
Q3 24
$-58.2K
$-639.3K
Q2 24
$363.5K
$581.8K
Q1 24
$-398.8K
$418.5K
Free Cash Flow
CVR
CVR
ICCC
ICCC
Q4 25
$24.3K
Q3 25
$492.1K
$-1.8M
Q2 25
$-22.8K
$1.4M
Q1 25
$-2.1M
$1.2M
Q4 24
$-118.1K
$-199.3K
Q3 24
$-368.9K
$-727.7K
Q2 24
$58.0K
$471.0K
Q1 24
$-491.8K
$348.1K
FCF Margin
CVR
CVR
ICCC
ICCC
Q4 25
0.4%
Q3 25
6.7%
-32.3%
Q2 25
-0.3%
22.4%
Q1 25
-28.3%
15.4%
Q4 24
-2.9%
-2.6%
Q3 24
-5.3%
-12.1%
Q2 24
0.7%
8.6%
Q1 24
-6.3%
4.8%
Capex Intensity
CVR
CVR
ICCC
ICCC
Q4 25
1.5%
Q3 25
2.0%
10.8%
Q2 25
0.7%
2.4%
Q1 25
0.6%
4.1%
Q4 24
1.4%
2.5%
Q3 24
4.5%
1.5%
Q2 24
3.8%
2.0%
Q1 24
1.2%
1.0%
Cash Conversion
CVR
CVR
ICCC
ICCC
Q4 25
Q3 25
9.44×
Q2 25
3.19×
Q1 25
-5.01×
1.09×
Q4 24
Q3 24
Q2 24
2.56×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVR
CVR

Fastener$5.1M85%
Other$890.7K15%

ICCC
ICCC

Segment breakdown not available.

Related Comparisons